Pacira Bids to Acquire Flexion to Expand Leadership Position in Non-Opioid Pain Management
Source: Streetwise Reports (10/11/2021)
Flexion Therapeutics Inc. shares traded 60% higher after the company reported it entered into a definitive agreement to be acquired by Pacira BioSciences Inc. for $8.00 per share in cash plus an additional non-tradeable contingent value right worth up to $8.00 per share in cash if five specific milestones are met.
read more >
Tech Firm to Develop Digital Credentials Verification System for Province's Convenience Stores
Source: Streetwise Reports (10/11/2021)
Once in place, this Smart Age program should result in Liquid Avatar Technologies growing organically in the short and long term.
read more >
Fabled One Payment Away From Owning Past-Producing, Silver-Gold Property in Mexico
Source: Streetwise Reports (10/11/2021)
The acquisition of Santa Maria will afford Fabled Silver Gold additional exploration and mining opportunities.
read more >
ChemoCentryx Shares Double After FDA Approves TAVNEOS™ for Treatment of ANCA-Associated Vasculitis
Source: Streetwise Reports (10/10/2021)
Shares of ChemoCentryx Inc. traded 96% higher after the company reported the U.S. FDA approved its orally administered TAVNEOS™ (avacopan) for use in treatment of ANCA-associated vasculitis, a systemic autoimmune disease that often results in kidney or other major organ damage and failure that can be fatal if left untreated.
read more >
Merus Shares Rise 37% After Firm Presents Multiclonic Antibodies Clinical Data to Molecular Targets & Cancer Therapeutics Summit
Source: Streetwise Reports (10/07/2021)
Merus NV shares traded higher after the company presented early and preclinical data for two full-length, multispecific antibodies, MCLA-158 and zenocutuzumab, to the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics.
read more >
Voyager Shares Lift Off After Firm Signs License Deal With Pfizer for Next-Gen AAV Capsids for Gene Therapy Programs
Source: Streetwise Reports (10/06/2021)
Shares of Voyager Therapeutics Inc. traded 51% higher after the company reported it entered into a license and option agreement with Pfizer Inc. for two of its TRACERᵀᴹ AAV capsids that will be utilized to enhance Pfizer's neurologic and cardiovascular gene therapy programs. Voyager will receive an upfront payment of $30 million and is eligible to receive up to $600 million more plus product sales-based royalties, if all options are exercised and certain milestones are achieved.
read more >
Silver Viper Seeks to ID High-Grade Silver at La Virginia in Mexico
Source: Streetwise Reports (10/06/2021)
Silver Viper aims to achieve this at La Virginia via a deep-penetrating geophysical survey of the El Rubi target.
read more >
Reliq's Telemedicine Platform Helps Free Up Hospital Space for COVID-19 Delta Patients
Source: Streetwise Reports (10/06/2021)
Simultaneously, demand is growing for Reliq Health's iUGO Care software as virtual healthcare delivery increases during the COVID-19 pandemic.
read more >
Blue Sky Implements Second Strategy to Advance Uranium District in Argentina
Source: Streetwise Reports (10/06/2021)
With two goals, to identify new mineralized deposits at Amarillo Grande and to expand the resource at the project's Ivana deposit, Blue Sky Uranium is carrying out two concurrent drill programs.
read more >
Live-Stream Entertainment Shopping Company OOOOO Seals Deal With TikTok
Source: Streetwise Reports (10/06/2021)
Shopping meets entertainment meets community in the latest form of online commerce, which just received a lift through its partnership with TikTok.
read more >